|
|
|
|
|
Aurelia Bustos and Antonio Pertusa
Interventional cancer clinical trials are generally too restrictive, and some patients are often excluded on the basis of comorbidity, past or concomitant treatments, or the fact that they are over a certain age. The efficacy and safety of new treatments...
ver más
|
|
|
|
|